Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis McCarty

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
AIDS and Behavior|July 24, 2010
Reducing HIV-related risk behaviors among injection drug users in residential detoxificationRobert E Booth, Barbara K Campbell, Susan K Mikulich-Gilbertson, et al.
Addictive Behaviors|January 3, 2012
Injection behaviors among injection drug users in treatment: the role of hepatitis C awarenessP Todd Korthuis, Daniel J Feaster, Zoilyn L Gomez, et al.
Substance Abuse|January 25, 2019
Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015Constance Weisner, Cynthia I Campbell, Andrea Altschuler, et al.
Journal of Psychoactive Drugs|January 30, 2025
Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training ProgramsJason B Luoma, Kim Hoffman, Adrianne R Wilson-Poe, et al.
Substance Abuse|October 4, 2021
Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force reportPaul J Joudrey, Gavin Bart, Robert K Brooner, et al.
The American Journal on Addictions|June 19, 2004
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experienceLeslie Amass, Walter Ling, Thomas E Freese, et al.
Drug and Alcohol Dependence|September 23, 2008
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependenceDouglas M Ziedonis, Leslie Amass, Marc Steinberg, et al.
Addiction (Abingdon, England)|February 7, 2022
HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trialP Todd Korthuis, Ryan R Cook, Paula J Lum, et al.
Journal of General Internal Medicine|November 6, 2023
Prescription Opioid Dose Reductions and Potential Adverse Events: a Multi-site Observational Cohort Study in Diverse US Health SystemsVerena E Metz, G Thomas Ray, Vanessa Palzes, et al.
JAMIA Open|June 2, 2022
Development and implementation of a prescription opioid registry across diverse health systemsG Thomas Ray, Andrea Altschuler, Ruchir Karmali, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
AIDS and Behavior|July 24, 2010
Reducing HIV-related risk behaviors among injection drug users in residential detoxificationRobert E Booth, Barbara K Campbell, Susan K Mikulich-Gilbertson, et al.
Addictive Behaviors|January 3, 2012
Injection behaviors among injection drug users in treatment: the role of hepatitis C awarenessP Todd Korthuis, Daniel J Feaster, Zoilyn L Gomez, et al.
Substance Abuse|January 25, 2019
Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015Constance Weisner, Cynthia I Campbell, Andrea Altschuler, et al.
Journal of Psychoactive Drugs|January 30, 2025
Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training ProgramsJason B Luoma, Kim Hoffman, Adrianne R Wilson-Poe, et al.
Substance Abuse|October 4, 2021
Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force reportPaul J Joudrey, Gavin Bart, Robert K Brooner, et al.
The American Journal on Addictions|June 19, 2004
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experienceLeslie Amass, Walter Ling, Thomas E Freese, et al.
Drug and Alcohol Dependence|September 23, 2008
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependenceDouglas M Ziedonis, Leslie Amass, Marc Steinberg, et al.
Addiction (Abingdon, England)|February 7, 2022
HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trialP Todd Korthuis, Ryan R Cook, Paula J Lum, et al.
Journal of General Internal Medicine|November 6, 2023
Prescription Opioid Dose Reductions and Potential Adverse Events: a Multi-site Observational Cohort Study in Diverse US Health SystemsVerena E Metz, G Thomas Ray, Vanessa Palzes, et al.
JAMIA Open|June 2, 2022
Development and implementation of a prescription opioid registry across diverse health systemsG Thomas Ray, Andrea Altschuler, Ruchir Karmali, et al.
Pageof 18